News, Conferences & Events

Explore our news page for a glimpse into our company's activities, featuring articles on conferences and scientific collaborations that drive innovation and industry trends.
MITACS Accelerate x SRL x uAlberta
MITACS Accelerate x SRL x uAlberta
We are pleased to announce that Dhanraj Kumawat, Ph.D. has been awarded a 2-year Mitacs Accelerate Post-Doctoral Fellowship in partnership between Sussex Research Laboratories Inc., and Professor Matthew Macauley of... Read more...
Sussex Research Laboratories Inc. Receives Support to Advance Oligonucleotide Therapeutics via Glycoscience
Sussex Research Laboratories Inc. Receives Support to Advance Oligonucleotide Therapeutics via Glycoscience
Sussex Research Laboratories Inc., a globally recognized and leading specialist empowering therapeutic innovation through glycoscience, is pleased to announce that it is receiving advisory services and funding from the National... Read more...
Happy Holidays from Sussex Research!
Happy Holidays from Sussex Research!
At Sussex Research Laboratories Inc., we operate in a highly specialized scientific space, one so complex that few are willing to take on the risk it demands. The field of... Read more...
Society for Glycobiology (SfG) Annual Meeting 2025
Society for Glycobiology (SfG) Annual Meeting 2025
Sussex Research Laboratories Inc. is proud to continue its long-standing participation in the Society for Glycobiology (SfG) Annual Meeting. We’re excited to once again sponsor this year’s event, taking place... Read more...
21st Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)
21st Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)
Sussex Research Laboratories Inc. is excited to be participating at the 21st Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) (OTS), taking place in Budapest, Hungary, from October 19–22, 2025.Oligonucleotide-based... Read more...
26th Annual RiboClub 2025
26th Annual RiboClub 2025
Sussex Research Laboratories Inc. is heading to RiboClub2025!After a very busy spring and summer, Sussex Research is looking forward to an exciting fall season. We’re pleased to announce that Mike... Read more...
4th Annual Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit
4th Annual Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit
Lipid-based nanoparticle innovation is advancing at lightning speed, especially priorities in achieving precise delivery beyond the liver. Join our CSO, Corwin Nycholat, at the 4th Annual Extra-Hepatic Lipid-Based Nanoparticles Delivery... Read more...
BIO International Convention 2025
BIO International Convention 2025
BIO International Convention, the world’s largest biotechnology event with over 20,000+ industry leaders from around the world, is taking place in Boston, Massachusetts from June 19-22, 2025. Boston will become... Read more...
CSC - Canadian Society of Chemistry
CSC - Canadian Society of Chemistry
Sussex Research Laboratories Inc. is pleased to announce our participation at the upcoming Canadian Chemistry Conference and Exhibition, taking place June 15–19, 2025, in our hometown and the nation’s capital... Read more...
Gordon Research Conferences - Carbohydrates
Gordon Research Conferences - Carbohydrates
Sussex Research Laboratories Inc. is pleased to contribute to the Gordon Research Conferences on Carbohydrates, to be held in Holderness, New Hampshire, from June 15-20, 2025.This prestigious conference brings together... Read more...
CGS - Canadian Glycomics Symposium & Glyco27
CGS - Canadian Glycomics Symposium & Glyco27
Sussex Research Laboratories Inc. is thrilled to be attending the joint Glyco27 and Canadian Glycomics Symposiums (#CGS2025), taking place in Edmonton, Alberta from May 25–30, 2025. It always feels like... Read more...
TIDES - Oligo & Peptide Therapeutics
TIDES - Oligo & Peptide Therapeutics
Sussex Research Laboratories Inc. have arrived at hashtag#TIDES2025! Our team is excited to discuss our industry-leading expertise in glycan-based solutions that advance hepatic & extra-hepatic targeted delivery of therapeutic payloads... Read more...
SDGS - San Diego Glycobiology Symposium
SDGS - San Diego Glycobiology Symposium
Sussex Research Laboratories Inc. is excited to be back as a sponsor and exhibitor for the upcoming San Diego Glycobiology Symposium (SDGS) on April 25, 2025 taking place at The... Read more...
ACS CARB: Celebrating a Legacy of Glycoscience: A Symposium Honoring Chi-Huey Wong
ACS CARB: Celebrating a Legacy of Glycoscience: A Symposium Honoring Chi-Huey Wong
Sussex Research Laboratories is proud to sponsor the ACS CARB event honoring Prof. Chi-Huey Wong on his 75th Birthday, "Celebrating a Legacy of Glycoscience: A Symposium Honoring Chi-Huey Wong". The... Read more...
Sussex Research Exhibits at Oligonucleotide Therapeutics Society (OTS2024) in Montreal
Sussex Research Exhibits at Oligonucleotide Therapeutics Society (OTS2024) in Montreal
Sussex Research Laboratories Inc. is your superhero for GalNAc ligands and targeted hepatic delivery of oligonucleotides.BUT… what about EXTRA-hepatic delivery?Talk to us – we’ll show you the power of glycotechnology... Read more...
Sussex Research Sponsors 7th Canadian Glycomics Symposium (#CGS2024) & the 10th Warren Workshop chaired by GlycoNet
Sussex Research Sponsors 7th Canadian Glycomics Symposium (#CGS2024) & the 10th Warren Workshop chaired by GlycoNet
Exciting news!  Sussex Research Laboratories Inc. is thrilled to announce our sponsorship and participation in the upcoming 7th Canadian Glycomics Symposium (#CGS2024) & the 10th Warren Workshop chaired by GlycoNet... Read more...
Sussex Research Participates in TIDES 2024 - Oligonucleotides & Peptide Therapeutics
Sussex Research Participates in TIDES 2024 - Oligonucleotides & Peptide Therapeutics
Exciting news from Sussex Research Laboratories Inc.! We're thrilled to announce our participation in this year's TIDES event in Boston on May 14-17. For over 25 years, we've been at... Read more...
Sussex Research Attends Helping With Furniture Charity Gala
Sussex Research Attends Helping With Furniture Charity Gala
On Friday, April 26th, our team had a delightful evening commemorating the 16th anniversary of the Helping With Furniture Gala. This event celebrated the remarkable work of Helping With Furniture,... Read more...
Sussex Research Laboratories Inc. Official Sponsor of San Diego Glycobiology Symposium (SDGS) 2024
Sussex Research Laboratories Inc. Official Sponsor of San Diego Glycobiology Symposium (SDGS) 2024
We are thrilled to announce that we are proudly sponsoring the 26th annual San Diego Glycobiology Symposium! Joining the event will be our CEO, Dr. Brady Clark, COO, Remmick So, and CSO,... Read more...
Sussex Research Laboratories Inc. to Exhibit at the 9th Annual OPT Congress
Sussex Research Laboratories Inc. to Exhibit at the 9th Annual OPT Congress
Sussex Research Laboratories Inc. is excited to announce its sponsorship and participation in the upcoming OPT Congress, the leading conference for advancements in oligonucleotides and mRNA therapeutics. Celebrating its 9th... Read more...
Sussex Research Laboratories Inc. to Exhibit at Society for Glycobiology's annual meeting Hawaii
Sussex Research Laboratories Inc. to Exhibit at Society for Glycobiology's annual meeting Hawaii
We're thrilled to announce our participation in the upcoming Society for Glycobiology's annual meeting in beautiful Hawaii from November 5th to 8th. We are excited to have our Chief Scientific Officer,... Read more...
Sussex Research Laboratories Inc. to Exhibit at BPS 2023 in Napa, California
Sussex Research Laboratories Inc. to Exhibit at BPS 2023 in Napa, California
Exciting news awaits! Sussex Research Laboratories Inc. is poised to unveil their pioneering strides in pharmaceutical development of peptide therapeutics at the highly anticipated Boulder Peptide Symposium (BPS) 2023, set... Read more...
Sussex Research Laboratories Inc. to Exhibit at Glyco26 in Taipei, Taiwan
Sussex Research Laboratories Inc. to Exhibit at Glyco26 in Taipei, Taiwan
Sussex Research Laboratories Inc., leading GalNAc and glycopeptide specialist, is excited to announce that we are exhibiting at the 26th International Glycoconjugate Symposium (IGS) - Glyco26 in Taipei, Taiwan! Visit us... Read more...
Sussex Research Laboratories Inc. Welcomes Dr. Nycholat as New CSO and Director of U.S. Subsidiary in San Diego
Sussex Research Laboratories Inc. Welcomes Dr. Nycholat as New CSO and Director of U.S. Subsidiary in San Diego
Sussex Research Laboratories Inc. (Sussex Research), a global leader in the translation of complex carbohydrate chemistries into unique, leading-edge products and services that enable researchers to explore and exploit glycomics... Read more...
Sussex Research Laboratories Inc. Official Sponsor of Glyconet's Canadian Glycomics Symposium 2023
Sussex Research Laboratories Inc. Official Sponsor of Glyconet's Canadian Glycomics Symposium 2023
Sussex Research Laboratories Inc., leading GalNAc and glycopeptide specialist, is excited to announce sponsorship of GlycoNet's Canadian Glycomics Symposium hosted in Edmonton, Alberta, Canada from May 10-12. For more information about... Read more...
Sussex Research Laboratories Inc. to Exhibit at TIDES USA 2023: Oligonucleotide & Peptide Therapeutics
Sussex Research Laboratories Inc. to Exhibit at TIDES USA 2023: Oligonucleotide & Peptide Therapeutics
Sussex Research Laboratories Inc., leading GalNAc and glycopeptide specialist, is excited to announce sponsorship of TIDES USA 2023: Oligonucleotide & Peptide Therapeutics. Visit us at booth 416 in San Diego, CA,... Read more...
Sussex Research Laboratories Inc. to Attend the Landmark Glycobiology Symposium (LGS)
Sussex Research Laboratories Inc. to Attend the Landmark Glycobiology Symposium (LGS)
Sussex Research Laboratories Inc., leading GalNAc and glycopeptide specialist, is excited to celebrate Prof. James C. Paulson and his contributions in the field of glycobiology at the Landmark Glycobiology Symposium (LGS)... Read more...
Sussex Research Laboratories Inc. to Attend the 25th Annual San Diego Glycobiology Symposium (SDGS)
Sussex Research Laboratories Inc. to Attend the 25th Annual San Diego Glycobiology Symposium (SDGS)
Sussex Research Laboratories Inc., leading GalNAc and glycopeptide specialist, is excited to announce sponsorship of the 25th Annual San Diego Glycobiology Symposium (SDSG) taking place in San Diego, California, USA on... Read more...
Sussex Research Laboratories Inc. to Exhibit at the 8th Annual OPT Congress
Sussex Research Laboratories Inc. to Exhibit at the 8th Annual OPT Congress
Sussex Research Laboratories Inc., leading GalNAc and carbohydrate targeting ligand specialist, is excited to announce sponsorship of the 8th Annual OPT Congress - Oligonucleotide & Precision Therapeutics! For over 25... Read more...
Sussex Research Laboratories Inc. Appoints Dr. Corwin Nycholat to Advisory Board
Sussex Research Laboratories Inc. Appoints Dr. Corwin Nycholat to Advisory Board
Sussex Research Laboratories Inc. (Sussex Research), a global leader in carbohydrate synthesis and the translation of complex carbohydrate chemistries into unique, leading-edge products that enable researchers to explore and exploit... Read more...
Sussex Research Laboratories Inc. to Exhibit at TIDES USA 2022: Oligonucleotide & Peptide Therapeutics
Sussex Research Laboratories Inc. to Exhibit at TIDES USA 2022: Oligonucleotide & Peptide Therapeutics
Sussex Research Laboratories Inc., leading GalNAc and glycopeptide specialist, is excited to announce sponsorship of TIDES USA 2022: Oligonucleotide & Peptide Therapeutics! For over 25 years, we have enabled application... Read more...
Sussex Research Laboratories Inc. to Exhibit at The American Peptide Symposium 2022 - "Peptide Science at the Summit"
Sussex Research Laboratories Inc. to Exhibit at The American Peptide Symposium 2022 - "Peptide Science at the Summit"
Great news! Sussex Research Laboratories Inc. will be exhibiting at The American Peptide Symposium (American Peptide Society) in Whistler, British Columbia, Canada! The symposium theme in 2022 is "Peptide Science at the... Read more...
Sussex Research Laboratories Inc. / Queen’s University collaboration receives support to develop novel small molecule therapies for COVID-19
Sussex Research Laboratories Inc. / Queen’s University collaboration receives support to develop novel small molecule therapies for COVID-19
Sussex Research Laboratories Inc. (Ottawa, Canada) today announced that Queen’s University and the Southeastern Ontario Academic Medical Organization (SEAMO) has awarded grants for two COVID-19 Rapid Response collaborations between Queen’s... Read more...
Sussex Research Laboratories Inc. / Queen’s University collaboration receives Collaborative Research and Development Grant (CRDPJ) to develop synthetic strategies toward Deuterium-labeled pharmaceutical compounds with improved efficacy
Sussex Research Laboratories Inc. / Queen’s University collaboration receives Collaborative Research and Development Grant (CRDPJ) to develop synthetic strategies toward Deuterium-labeled pharmaceutical compounds with improved efficacy
Sussex Research Laboratories Inc. (Ottawa, Canada) today announced that NSERC has approved the CRDPJ grant application submitted by Professor Victor Snieckus of the Department of Chemistry at Queen’s University (Kingston,... Read more...
Sussex Research Laboratories In. presents data on “Post Translationally Modified Cosmeceutical Actives” at the International Federation of Societies for Cosmetic Chemists (IFSCC) Congress in Paris
Sussex Research Laboratories In. presents data on “Post Translationally Modified Cosmeceutical Actives” at the International Federation of Societies for Cosmetic Chemists (IFSCC) Congress in Paris
Sussex Research Laboratories Inc. scientists presented data on the Company’s promising research & development program on carbohydrate-based anti-aging actives. Sussex Research Laboratories Inc. scientists presented the latest results on the... Read more...
Sussex Research Laboratories Inc. acquires Chemaphor Chemical Services from Avivagen
Sussex Research Laboratories Inc. acquires Chemaphor Chemical Services from Avivagen
Sussex Research Laboratories Inc., the leading specialist in the synthesis of carbohydrate and stable isotope-labeled molecules, is pleased to announce the successful acquisition of Chemaphor Chemical Services (“Chemaphor”) and its... Read more...
Sussex Research Laboratories Inc. receives Notice of Allowance for Glycopeptide Cosmetic Active technology patent
Sussex Research Laboratories Inc. receives Notice of Allowance for Glycopeptide Cosmetic Active technology patent
Sussex Research Laboratories Inc. Laboratories Inc., the leading specialist in carbohydrate synthesis, glycosylation and glycodesign, is pleased to announce that the U.S. Patent and Trademark Office has issued a Notice... Read more...
Sussex Research Laboratories Inc. announces successful Clinical Trial Results for Glycolastin its Novel Anti-Aging Glycopeptide Cosmetic Active
Sussex Research Laboratories Inc. announces successful Clinical Trial Results for Glycolastin its Novel Anti-Aging Glycopeptide Cosmetic Active
Sussex Research Laboratories Inc., the leading specialist in carbohydrate synthesis, glycosylation and glycodesign, is pleased to announce that its clinical trial for GlycolastinTM, an anti-aging glycopeptide cosmetic active, has successfully... Read more...
Sussex Research Laboratories Inc. collaborator receives grant to develop Glycan-Labelled BODIPY Fluorophores for use in glycobiology
Sussex Research Laboratories Inc. announced today that Professor Hongbin (Tony) Yan of Brock University has received an NSERC Engage grant for a project entitled Labelling glycans with BODIPY fluorophores. BODIPY fluorophores possess a number of unique properties that have led to their increasing popularity in a wide range of applications. Compared with other commercially available fluorophores such as fluoresceins, rhodamines, and cyanines, BODIPY fluorophores are in general more stable, both chemically and photochemically. Moreover, BODIPY fluorescent properties are relatively pH- and environment-independent, which is a very useful feature in many applications.... Read more...
Pharmaceutical Technology interviews Sussex Research Laboratories Inc. CEO, Dr. Brady Clark, on the “Role of NMR and Mass Spectroscopy in Glycan Analysis.”
Pharmaceutical Technology recently interviewed Sussex Research scientists, including Dr. Brady Clark, on the role of Nuclear Magnetic Resonance Spectroscopy (NMR) and Mass Spectrometry (MS) in Glycan Synthesis and Analysis. Sussex Research is a well known specialist in carbohydrate synthesis and glycodesign with an established international reputation. As discussed in the interview, NMR and MS are vital to successful development of glycosylation in syntheses of carbohydrate-based molecules and glycans. While NMR analysis provides crucial structural information of synthesized glycans that cannot be determined in any other way, MS analysis confirms molecular... Read more...
Sussex Research Laboratories Inc. presents data on “Post Translationally Modified Cosmeceutical Actives” at the Society for Cosmetic Chemists in New York
Sussex Research scientists gave the first glimpse into the Company’s promising research & development program on carbohydrate-based anti-aging actives. Sussex Research scientists presented the latest results on the Company’s anti-aging carbohydrate-based molecules at the annual Society for Cosmetic Chemists in New York. The poster, entitled “Post Translationally Modified Cosmeceutical Actives,” was extremely well received. Read more...
Sussex Research Laboratories Inc. collaborator receives NSERC grant to improve the manufacture of Pseudaminic Acid
Sussex Research Laboratories Inc. announced today that Professor Christopher N. Boddy of the University of Ottawa has received an NSERC Engage grant for a project entitled Development of a process for the manufacture of pseudaminic acid. Pseudaminic acid, a sialic acid (neuraminic acid) analogue, represents a promising new class of bacterial sugars with relevance in medicine and biology. Pseudaminic acid containing glycoconjugates are thought to influence pathogenesis through bacterial adhesion, invasion, and immune evasion, and are associated with bacterial cell surface structures such as lipopolysaccharide, capsular polysaccharide, pili and flagella. However,... Read more...
Sussex Research Laboratories Inc. appoints Wako Chemical Industries as a distributor for its carbohydrate-based products & services in Japan
Sussex Research Laboratories Inc. has appointed Wako Pure Chemical Industries (Osaka, Japan) as a non-exclusive distributor of Sussex’s complete line of carbohydrate-based reagents (glycoreagents) in Japan. Sussex Research develops and manufactures sophisticated carbohydrate-based molecules for advanced academic research as well as for research & development in the pharmaceutical and biotechnology industries. Under the new distribution agreement, Sussex glycoreagents are to be marketed under the Sussex Research label and sold, in research quantities, via Wako’s catalogue, sub-distributors and dealer network throughout Japan. According to Brady Clark, Ph.D., President of Sussex Research,... Read more...
Sussex Research Laboratories Inc. introduces unique sialic acid-like Pseudaminic Acid products for research into infectious diseases
Sussex Research, a leader in advanced glycosylation chemistry and carbohydrate synthesis, today announced that it now manufactures the rare bacterial saccharide, Pseudaminic Acid, along with its nucleotide activated form, CMP-Pseudaminic Acid. These unique saccharides are currently available commercially to researchers worldwide. Pseudaminic Acid (Pse) (5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero- -L-manno-nonulosonic acid) is a sialic acid-like, nine-carbon saccharide that was first identified in the lipopolysaccharides (LPS) of Pseudomonas aeruginosa in 1984. The sugar modification has since been observed in several other organisms including the gastrointestinal pathogens Helicobacter pylori and Campylobacter jejuni. The Pse saccharides are... Read more...
Sussex Research Laboratories Inc. and NRC Institute for Biological Sciences form Glycobiology Product Research and Development Agreement
Sussex Research Laboratories Inc. (Sussex) and the National Research Council (NRC) of Canada’s Institute for Biological Sciences (NRC-IBS) announced today the formation of a strategic research and development agreement designed to advance certain technologies that offer unique opportunities to exploit carbohydrate-based molecules for drug discovery. Sussex Research is expanding its glycoproducts commercialization efforts in the area of synthetic oligosaccharides and glycoconjugates by forging a strategic alliance with NRC-IBS. The company will collaborate directly with Dr. Dennis Whitfield of the Glycoconjugates and Tumour Immunology Group at NRC-IBS. Dr. Whitfield is a leader in... Read more...
Sussex Research Laboratories Inc. takes occupancy in new NRC Industry Partnership Facility
Sussex Research Laboratories Inc. (Sussex) announced that it is one of six technology-based companies to take occupancy in the new National Research Council (NRC) of Canada’s Industry Partnership Facility (IPF) located at NRC’s flagship site in Ottawa. The IPF exists to foster and assist companies commercializing NRC technologies or expertise, thereby providing economic gain to Canada, particularly to the National Capital Region. The incubating companies also occupy other offices and laboratories throughout the site. The site is also home to the NRC Steacie Institute for Molecular Sciences (NRC-SIMS), the NRC... Read more...